玖、 參考文獻
張恬嘉,2014。幾丁聚醣與魚油改善高脂飲食引起的大鼠肥胖及脂肪肝之研究。國立台灣海洋大學食品科學系碩士論文。陳艷琳,2013。幾丁聚醣改善高脂飲食誘發大白鼠肥胖及脂肪肝之機制探討。國立台灣海洋大學食品科學系碩士論文。曾憲鵬,2009,高、低分子量幾丁聚糖對正常及以streptozotocin-nicotinamide所誘發之第2型糖尿病大白鼠醣代謝和脂質代謝之影響。國立台灣海洋大學食品科學系碩士論文。馮仕安,2015。幾丁聚醣及幾丁寡醣對大白鼠血醣及血脂之研究。國立台灣海洋大學食品科學系碩士論文。黃杉頁,2004。高、低分子量幾丁聚糖對STZ所誘發之糖尿病大白鼠醣代謝與脂質代謝之影響。國立台灣海洋大學食品科學系碩士論文。蔡敏郎,1993。不同分子量、不同去乙醯程度的幾丁聚醣溶液的流變性質與膠囊物性的關係。國立臺灣海洋大學食品科學系碩士論文。
衛生福利部,2002。成人健康體位標準。台北。台灣。
衛生福利部,2013。台灣地區國民營養健康狀況變遷調查。台北。台灣。
衛生福利部,2014。民國103年國人十大死因統計。台北。台灣。
謝侑霖,2010。幾丁聚醣影響streptozotocin-nicotinamide 誘發之耐糖不良大白鼠脂肪組織之研究。國立台灣海洋大學食品科學系碩士論文。Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci USA 97: 1444–1449, 2000.
Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201–1204, 2004.
Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness GS, Rudel LL. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem 273: 26747–26754, 1998.
Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K,Hashimoto T, Gonzalez FJ (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273: 5678-5684.
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718-15723.
Balistreri CR, Caruso C, Candore G (2010) The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm 80: 20-78.
Begriche K, Igoudjil A, Pessayre D, Fromenty B (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6: 1-28.
Berger JJ, Barnard RJ (1999) Effect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol (1985) 87: 227-232.
Biddinger, S. B., Almind, K., Miyazaki, M., Kokkotou, E., Ntambi, J. M.; Kahn, C. R. (2005)Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes, 54 (5), 1314−1323.
Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab 292: E1740–E1749, 2007.
Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16.
Carling D (2004) The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci 29: 18-24.
Carlson SE, Goldfarb S (1977) A sensitive enzymatic method for determination of free and esterified tissue cholesterol. Clin Chim Acta 79: 575-582.
Carmen GY, Victor SM (2006) Signalling mechanisms regulating lipolysis. Cell Signal 18: 401-408.
Chancharme L, Therond P, Nigon F, Zarev S, Mallet A, Bruckert E, Chapman MJ (2002) LDL particle subclasses in hypercholesterolemia. Molecular determinants of reduced lipid hydroperoxide stability. J Lipid Res 43: 453-462.
Chen M, Yang Y, Braunstein E, Georgeson KE, Harmon CM. Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes. Am J Physiol Endocrinol Metab 281: E916– E923, 2001.
Chen YD, Risser TR, Cully M, Reaven GM (1979) Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity? Diabetes 28: 893-898.
Cheng HH and Lai MH. (2000) Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. The Journal of Nutrition. 130: 1991-1995.
Chiu, C.Y., Chan, I.L., Yang, T.H., Liu, S.H., Chiang, M.T. Supplementation of Chitosan Alleviates High-Fat Diet-Enhanced Lipogenesis in Rats via Adenosine Monophosphate (AMP)-Activated Protein Kinase Activation and Inhibition of Lipogenesis-Associated Genes. J. Agric. Food Chem , 2015, 63, 2979−2988.
Cho YS, Lee JI, Shin D, Kim HT, Jung HY, Lee TG, Kang LW, Ahn YJ, Cho HS, Heo YS. Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK. Biochem Biophys Res Commun, 2010 391: 187–192.
Clearfield MB. A novel therapeutic approach to dyslipidemia. J Am Osteopath Assoc 103: S16–S20, 2003.
Coleman RA, Haynes EB. Monoacylglycerol acyltransferase. Evidence that the activities from rat intestine and suckling liver are tissue-specific isoenzymes. J Biol Chem 261: 224–228, 1986.
Crane JD, Palanivel R, Mottillo EP, Bujak AL, Wang H, Ford RJ, Collins A, Blumer RM, Fullerton MD, Yabut JM, Kim JJ, Ghia JE, Hamza SM, Morrison KM, Schertzer JD, Dyck JR, Khan WI, Steinberg GR. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat Med 21: 166–172, 2015.
Cruz WS, Kwon G, Marshall CA, McDaniel ML, Semenkovich CF (2001) Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction. J Biol Chem 276: 12162-12168.
Day, C.P. From fat to inflammation. Gastroenterology, 2006, 130: 207-210.
Day CP, James OF (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
Deuchi K, Kanauchi O, Shizukuishi M, Kobayashi E (1994) Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high-fat diet. BBB 58:1613-1616.
Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD,Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343–1351, 2005.
Dowman JK, Tomlinson JW, Newsome PN (2010) Pathogenesis of non-alcoholic fatty liver disease. QJM 103: 71-83.
Drover VA, Ajmal M, Nassir F, Davidson NO, Nauli AM, Sahoo D, Tso P, Abumrad NA. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 115: 1290–1297, 2005.
Duval C, Muller M, Kersten S (2007) PPARalpha and dyslipidemia. Biochim Biophys Acta 1771: 961-971.
Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917 (1959).
Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456–461, 2011.
Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W and Desvergne B. (2001) Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding. Endocrinology 142(10):4195-4202.
Evans K, Burdge GC, Wootton SA (2008) Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia. Atherosclerosis 197:164-70.
Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S (2008) Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134: 424-431.
Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40: 185-194.
Fisher RM, Coppack SW, Humphreys SM, Gibbons GF, Frayn KN (1995) Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase. Clin Chim Acta 236: 7-17.
Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
Fon Tacer K, Rozman D (2011) Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. J Lipids78: 39-76.
for the hepatic steatosis, Clin Mol Hepatol 2013;19:210-214.
Fukada Y, Kimura K, Ayaki Y (1991) Effect of chitosan feeding on intestinal bile acid metabolism in rats. Lipids 26: 395-399.
Fungwe TV, Cagen L, Wilcox HG, Heimberg M (1992) Regulation of hepatic secretion of very low density lipoprotein by dietary cholesterol. J Lipid Res 33: 179-191.
Gaidhu, M.P., Anthony, N.M., Patel, P., Hawke, T.J., Ceddia, R.B., Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. J. Physiol, 2010,298(4), C961-C971.
Gallaher DD, Gallaher CM, Mahrt GJ, Carr TP, Hollingshead CH, Hesslink R, Wise J (2002) A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am Coll Nutr 21: 428-433.
Gao, Q., Jia, Y., Yang, G., Zhang, X., Boddu, P.C.,Petersen, B.,Narsingam, S., Zhu, Y.J. PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. J. Pathol, 2015,185 (5),1396-1408.
Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML (2003) Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278: 34268-34276.
Ge H, Cha JY, Gopal H, Harp C, Yu X, Repa JJ, Li C (2005) Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 46: 1484-1490.
Gleeson A, Anderton K, Owens D, Bennett A, Collins P, Johnson A, White D, Tomkin GH (1999) The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42: 944-948.
Goldberg IJ (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693-707.
Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest, 1995 96: 1382–1388.
Guo, J., Jou, W., Gavrilova, O., Hall, K. D. Persistent diet induced obesity in male C57BL/6 mice resulting from temporary obesigenic diets. PLoS One, 2009, 4 (4), No. e5370.
Hardie D.G. The AMP-activated protein kinase pathway--new players upstream and downstream. J Cell Sci, 2004, 117: 5479-5487.
Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett, 2003, 546: 113-120.
Harish Prashanth KV and Tharanathan RN (2007) Chitin/chitosan: modifications and their unlimited application potentialdan overview. Treneds Food Sci Tech 18: 117-131.
Hoffler, U., Hobbie, K., Wilson, R., Bai, R., Rahman, A., Malarkey, D., Travlos, G. and Ghanayem, B. I. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine, 2009, 36: 311-325.
Hofmann AF, Borgstrom B. Hydrolysis of long-chain monoglycerides in micellar solution by pancreatic lipase. Biochim Biophys Acta 70: 317–331, 1963.
Holm C (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31: 1120-1124.
Holt PR, Fairchild BM, Weiss J. A liquid crystalline phase in human intestinal contents during fat digestion. Lipids 21: 444–446, 1986.
Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H (1998) Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101: 2331-2339.
Hossain S, Rahman A, Kabir Y, Shams AA, Afros F, Hashimoto M (2007) Effects of shrimp (Macrobracium rosenbergii)-derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo- and hypercholesterolaemic rats. Clin Exp Pharmacol Physiol 34: 170-176.
Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H, Bakillah A. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta 1300: 151–170, 1996.
Hussain MM, Shi J, Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 44: 22–32, 2003.
Hussain MM. A proposed model for the assembly of chylomicrons. Atherosclerosis 148: 1–15, 2000.
Ikeda I, Sugano M, Yoshida K, Sasaki E, Iwamoto Y, Hatano K. Effects of chitosan hydrolysates on lipid absorption and on serum and liver lipid concentration in rats. J Agric Food Chem, 1993, 41:431-5.
Iqbal J, Dai K, Seimon T, Jungreis R, Oyadomari M, Kuriakose G, Ron D, Tabas I, Hussain MM. IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA. Cell Metab, 2008, 7: 445– 455.
Iqbal, J., Hussain, M.M.. Intestinal lipid absorption. Am. J. Physiol. Endocrinol. Metab – Endocrinology and Metabolism , 2009, 296:E1183–E1194.
Iyer SP, Yao X, Crona JH, Hoos LM, Tetzloff G, Davis HR Jr, Graziano MP, Altmann SW. Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochim Biophys Acta, 2005, 1722: 282–292.
Jamil, H.; Gordon, D. A.; Eustice, D. C.; Brooks, C. M.; Dickson, J. K., Jr.; Chen, Y.; Ricci, B.; Chu, C. H.; Harrity, T. W.; Ciosek, C. P., Jr.; Biller, S. A.; Gregg, R. E.; Wetterau, J. R. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (21), 11991− 11995.
Jayakumar R, Prabaharan M, Nair SV, Tokura S, Tamura H, Selvamurugan N (2010) Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications. Prog Mater Sci 55: 675-709.
Jayakumar R, Prabaharan M, Sudheesh Kumar PT, Nair SV, Tamura H (2011) Biomaterials based on chitin and chitosan in wound dressing applications. Biotech Adv 29: 322-337
Jennings CD, Boleyn K, Bridges SR, Wood PJ, Anderson JW (1988) A comparison of the lipid-lowering and intestinal morphological effects of cholestyramine, chitosan, and oat gum in rats. Proc Soc Exp Biol Med 189: 13-20.
Keller H, Mahfoudi A, Dreyer C, Hihi AK, Medin J, Ozato K, Wahli W. Peroxisome proliferator-activated receptors and lipid metabolism. Ann N Y Acad Sci,1993, 684: 157-173.
Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm CS, Lee ZH, Koh GY. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J,2000, 3463: 603-610.
Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ, Kim NG, Koh GY. Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem, 1999, 274: 26523-26528.
Knorr and Dietrich. (1984) Use of chitinous polymers in food: A challenge for food research and development. Food Technol-Chicago. 38, pp. 85–97
Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H, Furukawa H (2002) Angptl 3 regulates lipid metabolism in mice. Nat Genet 30: 151-157.
Koo S.H. Nonalcoholic fatty liver disease: molecular mechanisms
Kosaka S, Takahashi S, Masamura K, Kanehara H, Sakai J, Tohda G, Okada E, Oida K, Iwasaki T, Hattori H, Kodama T, Yamamoto T, Miyamori I (2001) Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation 103: 1142-1147.
Kuipers, F.; Jong, M. C.; Lin, Y.; Eck, M.; Havinga, R.; Bloks, V.; Verkade, H. J.; Hofker, M. H.; Moshage, H.; Berkel, T. J.; Vonk, R. J.; Havekes, L. M. Impaired secretion of very low density lipoproteintriglycerides by apolipoprotein E-deficient mouse hepatocytes. J. Clin. Invest. 1997, 100 (11), 2915−2922.
Kumar Suresh G., AtiarRahman Md., Lee Sung Hak, Hwang HeeSun, Kim Hyun Ah, Yun Jong Won (2009) Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9: 2149–2162
Kumar, Ravi, Majeti NV (2000) A review of chitin and chitosan applications. React Funct Polym 46: 1-27.
Kurita K. Chitin and chitosan: functional biopolymers from marine crustaceans. Mar Biotechnol,2006, 8: 203-226.
Kusunoki M, Hara T, Tsutsumi K, Nakamura T, Miyata T, Sakakibara F, Sakamoto S, Ogawa H, Nakaya Y, Storlien LH. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia, 2000, 43: 875-880.
Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology, 2014, 146: 726–735.
Lazar MA (2005) PPAR gamma, 10 years later. Biochimie 87: 9-13.
Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, Philippe J, Sibony M. Gasc JM, Corvol P, Germain S. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol, 2003, 162: 1521-1528.
Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, Patel SB. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet, 2001, 27: 79–83.
Lee RG, Willingham MC, Davis MA, Skinner KA, Rudel LL. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J Lipid Res 41: 1991–2001, 2000.
Lehoux JG, Grondin F. Some effect of chitosan on live function in the rat. Endocrinogy, 1993, 132:1078-1084.
Lehrke M, Lazar MA (2005) The many faces of PPARgamma. Cell 123: 993-999.
Lewis GF, Rader DJ (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96: 1221-1232.
Lewis GF, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K (2005) Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 146: 247-255.
Lim BO, Yamada K, Nonaka M, Kuramoto Y, Hung P, Sugano M Dietary fibers modulate indices of intestinal immune function in rats. J Nutr, 1997, 127: 663-667.
Lin EC, Fernandez ML, McNamara DJ (1992) Dietary fat type and cholesterol quantity interact to affect cholesterol metabolism in guinea pigs. J Nutr 122: 2019-2029.
Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N (1999) Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 38: 185-190.
Liu J, Zhang J, Xia W (2008) Hypocholesterolaemic effects of different chitosan samples in vitro and in vivo. Food Chem 107: 419-425.
Liu L, Ouyang D (2009) Function and clinical significance of microsomal triglyceride transfer protein. Int J Clin Exp Parho 29: 152-154.
Liu, S. H., C, Y. H. and Chiang, M. T. (2010) Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 58: 5795-5800.
Lopez-Velazquez JA, Carrillo-Cordova LD, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N (2012) Nuclear receptors in nonalcoholic Fatty liver disease. J Lipids 2012: 139-875.
Lu SN, Wang LY, Chang WY, Chen CJ, Su WP, Chen SC, Chuang WL, Hsieh MY (1990) Abdominal sonographic screening in a single community. Gaoxiong Yi Xue Ke Xue Za Zhi 6: 643-646.
Maezaki Y, Keisuke T, Nakagawa Y, Kawai Y, Akimoto M, Tsugita T, Takekawa W ,Terada A, Hara H, Mitsuoka T (1993) Hypocholesterolemic effect of chitosan in adult males. BBB 57:1439-1444.
Mason, T. M. 1998. The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes. Crit. Rev. Clin. Lab. Sci. 35: 461–487.
Gades, D. M., & Stern, J. S. (2003). Chitosan supplementation and fecal fat excretion in men. Obesity Research, 11, 683–688.
Mathur Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H, Furukawa H (2002) Angptl 3 regulates lipid metabolism in mice. Nat Genet 30: 151-157.
Mathur NK, Narang CK (1990) Chitin and chitosan, versatile marine animal polysaccharides. J Chem Educ 67: 938-942.
Mattijssen, F., Alex, S., Swarts, H.J., Groen, A.K., Schothorst, E.M., Kersten, S. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Molecular Metabolism, 2014, 3(2), 135-144.
Mattson FH, Volpenhein RA. The digestion and absorption of triglycerides. J Biol Chem 239: 2772–2777, 1964.
Maugeais C, Tietge UJ, Tsukamoto K, Glick JM, Rader DJ. Hepatic apolipoprotein E expression promotoes very low density lipoprotein-apolipoprotein B production in vivo in mice. J Lipid Res 2000; 41:1673-1679.
Meugnier, E., Bossu, C., Oliel, M., Jeanne, S., Michaut, A., Sothier, M., Brozek, J., Rome, S., Laville, M., Vidal, H. (2007) Changes in gene expression in skeletal muscle in response to fat overfeeding in lean men. Obesity (Silver Spring), 15 (11), 2583−2594.
Michael WK (2013) AMPK: Master metabolic regulator. Retrieves May 15, 2014 from http://themedicalbiochemistrypage.org/ampk.php
Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 2002, 415: 339-343.
Misra, P and Reddy, J.K.: Peroxisome proliferator-activated receptor-alpha activation and excess energy burning in hepatocarcinogenesis. Biochimie, 2014, 98:63-74.
Moreau RA, Whitaker BD, Hicks KB. Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Prog Lipid Res, 2002, 41: 457–500.
Munday MR, Campbell DG, Carling D, Hardie DG. Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur J Biochem 175: 331–338, 1988.
Muzzarelli RAA, Rocchetti. Determination of the degree of acetylation of chitosan by first derivative ultraviolet spectrophotometry. Carbohyd Polym, 1985, 5: 461-472.
National Center for Chronic Disease Prevention and Health Promotion (2014) 2014 National Diabetes Statistics Report Retrieves August 17, 2015 from http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html
Nelson GJ, Blood lipids and lipoproteins: quantitation, composition, and metabolism. Wiley-Interscience. New York,U S A, 1972.
Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 113: 1582–1588, 2004.
Niemeier A, Gafvels M, Heeren J, Meyer N, Angelin B, Beisiegel U (1996) VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J Lipid Res 37: 1733-1742.
Oike Y, Akao M, Kubota Y, Suda T (2005) Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 11: 473-479.
Oike Y, Ito Y, Maekawa H, Morisada T, Kubota Y, Akao M, Urano T, Yasunaga K Suda T Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood. Am Soc Hematology, 2004, 103: 3760-3765.
Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y, Koishi R, Furukawa H. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL 3): ANGPTL 3 is cleaved and activated in vivo. J Biol Chem, 2003, 278: 41804-41809.
Perry RJ, Camporez JP, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM, Ruan HB, Yang X, Caprio S, Kaech SM, Sul HS, Birnbaum MJ, Davis RJ, Cline GW, Petersen KF, Shulman GI. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell, 2015, 160: 745–758.
Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, Tomkin GH. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism, 2002, 51: 847-852.
Phillips C, Owens D, Collins P, Tomkin GH. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly? Atherosclerosis, 2002, 160: 355-360.
Quintao EC, Sperotto G (1987) The role of dietary cholesterol in the regulation of human body cholesterol metabolism. Adv Lipid Res 22: 173-188.
Romao JM, Jin W, Dodson MV, Hausman GJ, Moore SS, Guan LL (2011) MicroRNA regulation in mammalian adipogenesis. Exp Biol Med (Maywood) 236: 997-1004.
Rutter GA, Da Silva Xavier G, Leclerc I (2003) Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375: 1-16.
Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79: 427–436, 1994.
Semenkovich, C. F. and Heinecke, J. W. (1997) The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 46: 327-334.
Sessions VA, Salter AM (1994) The effects of different dietary fats and cholesterol on serum lipoprotein concentrations in hamsters. Biochim Biophys Acta 1211: 207-214.
Shan, L.; Yu, X. C.; Liu, Z.; Hu, Y.; Sturgis, L. T.; Miranda, M. L.; Liu, Q. (2009) The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J. Biol. Chem, 284 (3), 1419−1424
Shi, Y., Burn, P., 2004. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat. Rev. Drug. Discov. 3(8):695–710.
Shiau, S.Y., Chang, G.W., (1983) Effects of dietary fiber on fecal mucinase and β-glucuronidase activity in rats. J Nutr, 113, pp. 138–144
Shimamura M, Matsuda M, Kobayashi S, Ando Y, Ono M, Koishi R, Furukawa H, Makishima M, Shimomura I (2003) Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun 301: 604-609.
Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99: 846-854.
Smith, B.K., Marcinko, K., Desjardins, E.D., Lally, J.S., Ford, R.J., Steinberg, G.R. Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab, 2016, 311: E730–E740.
Sparks JD, Sparks CE (2008) Overindulgence and metabolic syndrome: is FoxO1 a missing link? J Clin Invest 118: 2012-2015.
Sparks JD, Sparks CE, Adeli K. (2012) Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 32:2104-12.
Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev 89: 1025–1078, 2009.
Stryer L. (1998) Biochemistry, 3rd edn. Academic press, U S A.
Sugano M, Fujikawa Y, Hiratsuji K, Nakashima N, Hasegawa Y (1980). A novel use of chitosan as a hypocholesterolemic agent in rats. Am J Clin Nutr 33: 787-793.
Sukonina V, Lookene A, Olivecrona T, Olivecrona G (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci U S A 103: 17450-17455.
Sumiyoshi M, Kimura Y (2006) Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharm Pharmacol 10.1211/jpp.58.2.0007.
Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT (2004) The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb 11: 200-208.
Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T (1995) Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270: 15747-15754.
Takehisa F, Suzuki Y (1990) Effect of guar gum and cholestyramine on plasma lipoprotein cholesterol in rats. J Jpn Soc Food Sci 43: 269-274.
Tamura S, Shimomura I (2005) Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 115: 1139-1142.
Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res 2004;45:941-947. 42. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000;20:663-697.
Taskinen MR, Adiels M, Westerbacka J (2012) Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects. Arterioscler Thromb Vasc Biol 31:2144e50.
Terbojevich M, Cosani A, Focher B and Marsano E (1993). High-performance gel-permeation chromatography of chitosan samples.Carbogydrates Research. 250: 301-314.
Toei K and Kohara T. A conductometric method for colloid titrations. Analytica Chimica Acta, 1976, 83: 59-65.
Trayhurn P and Beattie JH Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings of The Nutrition Society, 2001,60: 329-339.
Van de Velde K, Kiekens P. Structure analysis and degree of substitution of chitin, chitosan and debutyrylchitin by FT-IR spectroscopy and solid state C-13 NMR. Carbohyd Polym, 2004, 58: 409-416.
van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, Staels B, Groot PH, Groen AK, Kuipers F. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res, 2005, 46: 526–534.
Van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, Davis HR Jr. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 129: 1748–1754, 2000.
Vårum KM, Ottoy MHl and Smidsorod O. Acid hydrolysis of chitosans carbohydrate polymers, 2001, 46:89-98.
Wang W, Bo SQ, Li SQ, Qin W. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int J Biol Macromol, 1991, 13: 281-285.
Wang, T.Y., Liu, M., Portincasa, P., Wang, D.Q. New insights into the
Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12: 1106-1110.
Watson KE, Horowitz BN, Matson G (2003) Lipid abnormalities in insulin resistant states. Rev Cardiovasc Med 4: 228-236.
Whitcomb, D.C., Lowe, M.E., 2007. Human pancreatic digestive enzymes. Digestive Diseases and Sciences 52 (1):1–17.
White DA, Bennett AJ, Billett MA, Salter AM (1998) The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein. Br J Nutr 80: 219-229.
Wickelgren I (1998) Obesity: How big a problem? Science 280: 1364-1367.
Wilson MD, Rudel LL. Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J Lipid Res 35: 943–955, 1994.
World Health Organization (2006) Data and statistics, diabetes, definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Retrieved June 27, 2009 from http://www.who.int/diabetes/facts/en/index.html.
World Health Organizaton (2004) BMI classification. Global database on body mass index. Retrieves May 15, 2004 from http://apps.who.int/bmi/index.jsp?introPage=intro3.html.
World Health Organizaton (2005) The World Health Organizaton warns of the rising threat of heart disease and stroke as overwight and obesity rapidly increase. Retrieves May 11, 2014 from http://apps.who.int/mediacentre/news/releases/2005/pr44/en/.
World Health Organizaton (2015) Obesity and overweight. Retrieves August 17, 2015 from http://www.who.int/mediacentre/factsheets/fs311/en/
Xu G, Huang X, Qiu L, Wu J, Hu Y (2007 (B)) Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pac J Clin Nutr 16 Suppl 1: 313-317.
Xu XJ, Gauthier MS, Hess DT, Apovian CM, Cacicedo JM, Gokce N, Farb M, Valentine RJ, Ruderman NB. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res 53: 792–801, 2012.
Yamamoto T, Takahashi S, Sakai J, Kawarabayasi Y (1993) The very low density lipoprotein receptor A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc Med 3: 144-148.
Yang PM, Huang GT, Sheu JC, Hung CM, Lin YM, Lai MY,Chen DS, Sung JL (1986) Mass screening of hepatobiliary diseases by real-time ultrasonography. Taiwan Yi Xue Hui Za Zhi 85: 1144-1150.
Yao HT, Chiang MT. (2006) Chitosan shifts the fermentation site toward the distal colon and increases the fecal short-chain fatty acids concentrations in rats. Int J Vitam Nutr Res 76: 57-64.
Yao HT, Huang SY, Chiang MT (2008) A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem Toxicol 46: 1525-1534.
Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 49: 2283–2301, 2008.
Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9–14, 2011.
Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, Michaely P, Liu P, Willingham MC, Rudel LL. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 281: 6616–6624, 2006.
Zander M1, Madsbad S, Madsen JL, Holst JJ (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 824-30
Zeng L, Qin C, Wang W, Chi W, Li W (2008) Absorption and distribution of chitosan in mice after oral administration. Carbohydrate Polymers 71. 435–440.
Zhang D, Liu ZX, Choi CS, Tian L, Kibbey R, Dong J, Cline GW, Wood PA, Shulman GI. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA 104: 17075–17080, 2007.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
Sugano, M.; Watanabe, S.; Kishi, A.; Izume, M.; Ohtakara, A. Hypocholesterolemic action of chitosans with different viscosity in rata. Lipids 1988, 23, 187-191.
Zhang, J., Zhang, W., Mamadouba, B., Xia, W. (2012) A comparative study on hypolipidemic activities of high and low molecular weight chitosan in rats. Int. J. Biol. Macromol. 51:504-508.
Zhu S, St-Onge MP, Heshka S, Heymsfield SB. 2004. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 53: 1503-1511
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, Andrea FD, Molinari AM, Giugliano D (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804-809.